 |
Previous Article | Next Article 
The Journal of Neuroscience, August 1, 2002, 22(15):6353-6361
Receptor for Activated C Kinase-1 Facilitates Protein Kinase
C-Dependent Phosphorylation and Functional Modulation of
GABAA Receptors with the Activation of G-Protein-Coupled
Receptors
Nicholas J.
Brandon1,
Jasmina N.
Jovanovic1,
Trevor G.
Smart2, and
Stephen J.
Moss1
1 Medical Research Council, Laboratory of Molecular
Cell Biology and Department of Pharmacology, University College London,
London WC1E 6BT, United Kingdom, and 2 Department of
Pharmacology, The School of Pharmacy, London WC1N 1AX, United Kingdom
 |
ABSTRACT |
GABAA receptors are the principal sites of fast
synaptic inhibition in the brain. These receptors are hetero-pentamers
that can be assembled from a number of subunit classes: (1-6),
(1-3), (1-3), (1), , , and , but the majority of
receptor subtypes is believed, however, to be composed of ,
, and 2 subunits. A major mechanism for modulating
GABAA receptor function occurs via the phosphorylation of
residues within the intracellular domains of receptor subunits by a
range of serine/threonine and tyrosine kinases. However, how protein
kinases are targeted to these receptors to facilitate functional
modulation remains unknown. Here we demonstrate that the receptor for
activated C kinase (RACK-1) and protein kinase C (PKC) bind to distinct
sites on GABAA receptor subunits. Although RACK-1 is
not essential for PKC binding to GABAA receptor subunits, it enhances the phosphorylation of serine 409, a residue critical for the phospho-dependent modulation of GABAA
receptor function in the 1 subunit by anchored PKC. Furthermore,
RACK-1 also enhances GABAA receptor functional modulation
in neurons by a PKC-dependent signaling pathway with the activation of
muscarinic acetylcholine receptors (mAChRs). This PKC-dependent
modulation of neuronal GABAA receptors was mirrored by an
increase in the phosphorylation of GABAA receptor subunits with the activation of mAChRs.
Our results suggest a central role for RACK-1 in potentiating
PKC-dependent phosphorylation and functional modulation of
GABAA receptors. Therefore, RACK-1 will enhance functional
cross talk between GABAA receptors and G-protein-coupled
receptors and therefore may have profound effects on neuronal excitability.
Key words:
GABAA receptor; protein kinase C; receptor
for activated C kinase; muscarinic receptor phosphorylation; cross
talk; GST fusion protein
 |
INTRODUCTION |
GABAA
receptors mediate the majority of fast inhibitory neurotransmission in
the brain (Rabow et al., 1995 ). These receptors are hetero-pentamers
that can be assembled from a wide range of receptor subunits:
(1-6), (1-3), (1-3), , , and (Rabow et
al., 1995 ; Davies et al., 1997 ; Bonnert et al., 1999 ). In the brain
most GABAA receptor subtypes are believed to be
composed of , , and 2 subunits (Rabow et al., 1995 ).
The exogenous regulation of GABAA receptor
function by benzodiazepines and barbiturates is well established (Rabow
et al., 1995 ). In contrast, the endogenous mechanisms that control
receptor function remain only partly characterized, with receptor
phosphorylation as a mechanism proposed to be of major significance
(Brandon et al., 2000 ). It is evident that the
GABAA receptor 1- 3 and 2 subunits are
the substrates of a number of protein kinases, including cAMP-dependent
protein kinase (PKA), protein kinase C (PKC), cGMP-dependent protein
kinase, and Ca/calmodulin-dependent protein kinase II (CamKII) (Moss et
al., 1992a ,b ; Krishek et al., 1994 ; McDonald and Moss, 1997 ;
McDonald et al., 1998 ). GABAA receptor subunits are all phosphorylated by PKC on highly conserved serine (S)
residues (S409 in the 1 and 3 subunits and S410 in the 2
subunit) (Krishek et al., 1994 ; McDonald et al., 1998 ). Moreover, for
recombinant GABAA receptors the phosphorylation
of these residues has been correlated directly with functional
modulation (Kellenberger et al., 1992 ; Krishek et al., 1994 ; Lin et
al., 1996 ). In addition, there is evidence from heterologous expression
systems that PKC activity can modify receptor trafficking, an effect
that appears to be independent of direct receptor phosphorylation (Moss
and Smart, 2001 ). In neurons the receptor subunits also are
phosphorylated by PKC-dependent signaling pathways, and there is
extensive evidence that the activation of PKC can modify neuronal
GABAA receptor function (Browning et al., 1990 ;
Brunig et al., 1999 ; Poisbeau et al., 1999 ; Brandon et al., 2000b ).
Although progress has been made in identifying which
GABAA receptor subunits are protein kinase
substrates, presently little is understood about how kinases are
targeted to these receptors to facilitate subunit-specific
phosphorylation. Here we have examined the functional significance of
the direct but independent interactions between the receptor for
activated C kinase (RACK-1) and PKC- II/ isoforms with
GABAA receptors (Brandon et al., 1999 ). RACK-1 is essential for PKC-mediated phosphorylation of
GABAA receptor subunits and functional modulation
of the receptor by PKC-dependent signaling pathways after the
activation of muscarinic acetylcholine receptors (mAChRs). Although
RACK-1 is believed to function primarily as a "shuttle or anchoring
protein," facilitating the targeting of the and II PKC
isoforms to their substrates (Chang et al., 1998 ; Liliental et al.,
1998 ; Ron et al., 1999 ; Yarwood et al., 1999 ; Jaken and Parker, 2000 ),
our results suggests a new insight into the role of RACK-1, acting to
potentiate the catalytic activity of PKC anchored at
GABAA receptors without affecting interaction with receptor subunits. This study demonstrates a new role for RACK-1
in modulating GABAA receptor phosphorylation and
the functional modulation by PKC-dependent cell signaling pathways.
 |
MATERIALS AND METHODS |
Antibodies. The following primary antibodies were
used for immunoblotting: a mouse monoclonal to RACK-1 (1:1000 dilution; Transduction Labs, Lexington, KY), a rabbit polyclonal to PKC isoforms
, , and (1:500 dilution; Upstate Biotechnology, Lake Placid,
NY), an antibody specific for the PKC- II isoform (Brandon et al.,
1999 ), or a rabbit polyclonal antiserum against the intracellular domain of the GABAA receptor (Tretter et al.,
1997 ; Brandon et al., 1999 ). The following primary antibodies were used
for immunoprecipitation: a mouse monoclonal antibody against the 9E10
epitope (9E10 clone, 5 µg/ml; a kind gift of G. Evan, Ludwig
Institute, London, UK) (Connolly et al., 1996 ) and a rabbit
polyclonal antibody to GABAA receptor 1/ 3
subunits (Moss et al., 1992a ,b ; Krishek et al., 1994 ). To
evaluate GABAA receptor phosphorylation, we
used a phospho-specific antiserum that recognizes only
phosphorylated serine residues 408 and 409 within the murine
GABAA receptor 3 subunit (UCL 39; 1:50)
(Jovanovic et al., 2001 ).
Expression constructs. Glutathione S-transferase
(GST) fusion protein constructs of the GABAA 1
subunit were made by PCR amplification (Smith and Johnson, 1988 ;
Brandon et al., 1999 ). A GST fusion protein of RACK-1 was constructed
with the entire coding sequence of RACK-1 from a rat RACK-1 cDNA (Ron
et al., 1994 ). The RACK-1 cDNA was a kind gift of D. Mochly-Rosen
(University of California at San Francisco, San Francisco, CA).
The 9E10-tagged GABAA receptor 1 and 1
expression constructs in pRK5 have been described previously (Krishek
et al., 1994 ; Connolly et al., 1996 ).
GST protein "pull down" assays. Brains from adult
Sprague Dawley rats were prepared in lysis buffer [10 mM
triethanolamine, pH 7.6, 1% Nonidet P-40, 0.5% deoxycholate, and (in
mM) 150 NaCl, 5 EGTA, 5 EDTA, 50 NaF, 1 Na-orthovanadate,
100 PMSF plus 10 µg/ml leupeptin, pepstatin, antipain, and
aprotinin] (Brandon et al., 1999 ). Insoluble material was removed by
centrifugation. Lysates were exposed to GST fusion proteins on
glutathione-agarose beads at 4°C for 2 hr. The beads were washed
twice in 0.4% NP-40 and (in mM) 500 NaCl, 10 triethanolamine, pH 7.6, 5 EGTA, 5 EDTA, 1 Na-orthovanadate, and 1 PMSF
and then twice in the same buffer supplemented with 150 mM
NaCl. Proteins bound to the beads were separated by SDS-PAGE and
analyzed by Western blotting or by an in vitro kinase assay
and autoradiography. For the peptide competition assays after
incubation with brain extract the beads were washed twice in pull down
buffer, and peptides were added to a 100 nM final
concentration (Billups et al., 2000 ). After rotation for 30 min at
4°C the beads were washed again with lysis buffer and then
resuspended in SDS-PAGE sample buffer. Proteins bound to the beads were
separated by SDS-PAGE and analyzed by Western blotting. The RACK-1
binding site competitive peptide had the sequence RHGVPGKGRI, whereas
the scrambled control peptide had the sequence RRGGGIKPVH.
In vitro kinase assays and PKA phosphorylation. To
analyze the phosphorylation of GABAA receptor
subunits by associating protein kinases, we washed beads from pull down
assays or immunoprecipitations twice in kinase buffer [containing (in
mM) 20 Tris, pH 7.4, 20 MgCl2, 1 EDTA, 1 EGTA, 1 ouabain, 1 Na-orthovanadate, 0.1 DTT, 2 MnCl2] and resuspended them finally in 50 µl
of kinase buffer containing 3-30 µCi
32 P-ATP (Amersham Biosciences,
Piscataway, NJ). The reactions were incubated at 30°C for 15 min.
Beads were pelleted, and bound material was separated by SDS-PAGE.
Phosphorylation of the 1 subunit was quantified by the use of a
Bio-Rad PhosphorImager (Hercules, CA). For the PKA phosphorylation
experiments (Moss et al., 1992a ,b ) fusion proteins were
phosphorylated for 10 min at 30°C with purified PKA (Promega,
Madison, WI); after extensive washing, they were exposed to brain extracts.
Filter overlay binding assays. Filter overlay assays were
performed as described previously. GST fusion proteins of the
GABAA receptor 1 subunit and GST alone were
separated by SDS-PAGE, transferred to nitrocellulose membrane, and
subjected to a guanidine denaturing-renaturing process in overlay
buffer (10 mM HEPES, pH 7.5, 70 mM KCl, 5 mM EDTA). The filter was blocked in overlay buffer
supplemented with 5% milk and then incubated with
32P-labeled GST-RACK-1 overnight at 4°C.
After extensive washing in overlay buffer, the bound
32P-labeled GST-RACK-1 was detected by autoradiography.
Cell transfection and immunoprecipitation. Human embryonic
kidney (HEK) 293 cells were transfected with the indicated constructs, left for 24 hr, and solubilized with a buffer containing 2% Triton X-100 (Krishek et al., 1994 ; Brandon et al., 1999 ). Brain lysates were
prepared from adult rat brain under similar conditions (Brandon et al.,
1999 ). Then GABAA receptors were isolated by
using anti- 1/ 3 sera coupled to protein A-Sepharose (Moss et al.,
1992a ,b ; Krishek et al., 1994 ). Precipitated proteins were
separated by SDS-PAGE and analyzed by immunoblotting. In some cases HEK
293 cells were labeled metabolically with
[35S]methionine for 3 hr before
immunoprecipitation; then the labeled receptor subunits were visualized
by fluorography.
Patch-clamp electrophysiology. Whole-cell GABA currents were
recorded from single HEK 293 cells by a List EPC7 amplifier. Patch
electrodes (resistance, 2-6 M ) were filled with a solution containing (in mM): 140 KCl, 2 MgCl2,
1 CaCl2, 10 HEPES, 11 EGTA, and 2 adenosine
triphosphate, pH 7.2. Cells were superfused continuously with a Krebs'
solution containing (in mM): 140 NaCl, 4.7 KCl, 1.2 MgCl2, 2.5 CaCl2, 10 HEPES,
and 11 glucose, pH 7.4. Recordings were performed at 25°C, 24-48 hr
after transfection voltage clamping at 40 mV (filtering at 5 kHz; 3
dB, sixth pole Bessel; 36 dB/octave). Drugs and Krebs' solution were
applied rapidly to HEK 293 cells via a modified U tube. All drugs were
dissolved in Krebs' solution. The RACK-1 peptides, GST fusion
proteins, and PKC inhibitor peptide were dissolved directly in the
patch pipette solution, whereas a stock solution of phorbol
12-myristate, 13-acetate (PMA; 0.5 mg/ml) was made in DMSO and diluted
with a patch pipette solution (0.06% final DMSO concentration, which
was inactive).
HEK 293 and neuronal cultures. HEK 293 cells were grown in
DMEM supplemented with 10% fetal calf serum, 2 mM
glutamine, 100 U/ml penicillin G, and 100 µg/ml streptomycin at
37°C in 95% air/5% CO2. Cells were
electroporated with plasmids containing wild-type or mutant
GABAA receptor subunit cDNAs together with a
reporter plasmid expressing jellyfish green fluorescent protein. Rat
superior cervical ganglion and cortical neurons were cultured as
described previously (Krishek et al., 1994 ).
 |
RESULTS |
PKC and RACK-1 bind to distinct domains on the GABAA
receptor 1 subunit
We have demonstrated previously that RACK-1 and activated
PKC- II bind directly but independently to
GABAA receptor subunits (Brandon et al.,
1999 ). To map the binding sites of RACK-1 and PKC in these proteins, we
produced GST fusion protein constructs encoding regions of the major
intracellular domain of the GABAA receptor 1
subunit (residues 302-426; GST- 1) (Moss et al., 1992a ,b ; Brandon et al., 1999 ). To identify the residues responsible for the
binding of RACK-1, we incubated these proteins with recombinant RACK-1
expressed as a GST fusion protein in gel overlay assays. Using this
approach, we were able to establish that RACK-1 binds to the C-terminal
half of the 1 subunit intracellular domain between residues 395 and
404 (residues RHGVPGKGRI) (Fig.
1A,B). The binding site
for RACK-1 lies immediately upstream of Serine 409 (S409), which is a
known substrate of PKC in addition to PKA and is of critical importance
for GABAA receptor functional modulation with the
PKC activation (Moss et al., 1992a ,b , 1995 ; Krishek et al.,
1994 ). However, the binding of RACK-1 to the intracellular domain of
the 1 subunit is independent of S409, as shown by the positive
interaction with the 366-404 construct, which does not contain this
residue (Fig. 1A,B).

View larger version (29K):
[in this window]
[in a new window]
|
Figure 1.
RACK-1 and PKC bind to differing sites
on the GABAA receptor 1 subunit. A, The
RACK-1 binding site was identified by using filter overlay assays.
Shown is 2 µg of a series of GST fusion protein deletion constructs
encoding the residues; residues 302-426 (GST- 1; lane
1), 302-365 (lane 2), 366-394 (lane
3), 395-426 (lane 4), 366-404
(lane 5), and 366-415 (lane 6) of
the GABAA receptor 1 subunit intracellular domain or GST
alone (lane 7) were separated by SDS-PAGE. Then
duplicate gels were transferred to a nitrocellulose membrane and
incubated with [32P]-labeled RACK-1
(right) or were stained with Coomassie blue to
demonstrate equal loading of GST fusion proteins (left).
The binding of RACK-1 was quantified with a PhosphorImager.
B, The relative binding of PKC and RACK-1 to truncations
of the 1 subunit intracellular domains as derived from overlay and
pull down assays. +++, Binding similar (>95%) to control (GST 3
302-426); ++, 60% binding relative to control; , no detectable
binding. Similar results were obtained in four separate experiments.
C, The PKC binding site was identified with GST pull
down assays. GST fusion protein deletion constructs encoding residues
302-426 (GST- 1; lane 1), 302-365 (lane
2), 366-394 (lane 3), 395-426 (lane
4), 366-404 (lane 5), and 366-415
(lane 6) of the GABAA 1
subunit intracellular domain or GST alone (lane
7) were incubated with adult rat brain extracts, washed,
and separated by SDS-PAGE and immunoblotting with anti-PKC- II.
Lane 8 represents 10% of the total brain extract that
was exposed to the fusion proteins. The data are representative of
three independent experiments. D, PKC associates with
the 1 subunit intracellular domain independently of S409. GST fusion
proteins encoding the entire intracellular domain of the 1 subunit
(lane 1) or the mutant fusion protein
GST- 1S409A (lane 2) or GST alone
(lane 3) were incubated with adult rat brain extracts,
washed, and separated by SDS-PAGE. Immunoblotting with anti-PKC- II
was performed to detect associating PKC. Lane 4
represents 10% of the total brain extract that was exposed to the
fusion proteins. The data are representative of three independent
experiments. E, Schematic diagram of proposed distinct
binding sites for RACK-1 (residues 395-404) and PKC (residues
405-415).
|
|
To identify the binding site for PKC on the intracellular domain of the
GABAA 1 subunit, we used GST-affinity
purification (pull down) assays from brain lysates. This methodology
was used because we were unable to produce large amounts of the
PKC- II isoform (Brandon et al., 1999 ) required for use in gel
overlay assays. PKC bound to a number of differing
GABAA receptor 1 subunit constructs. This
allowed us to deduce that the PKC was binding to the region between
regions 405 and 415 (IRRRASQLKVKI) within the intracellular domain of
the 1 subunit, straddling the phospho-acceptor site S409 (Fig.
1B,C). This site is immediately downstream of where
we propose RACK-1 binds and agrees with the observation that the two
molecules can bind independently of each other (Brandon et al., 1999 ).
Serine 409 is not absolutely critical for this interaction, because PKC
still binds to the mutant fusion protein where S409 has been mutated to
an alanine residue (GST- 1S409A) (Fig.
1D) (Brandon et al., 1999 ). We have demonstrated
previously that PKC- II and RACK-1 interact directly in neurons and
in vitro (Brandon et al., 1999 ), consistent with
observations in other systems (Ron et al., 1999 ; Jaken and Parker,
2000 ).
Together, our observations suggest that PKC and RACK-1 bind
independently to distinct residues within the
GABAA receptor 1 subunit (Fig.
1E). Therefore, RACK-1 may facilitate the targeting of PKC activity to its substrate S409 in this protein or play a role in
regulating PKC activity at the GABAA receptor
(Ron et al., 1999 ; Jaken and Parker, 2000 ).
RACK-1 facilitates PKC-mediated phosphorylation of the
GABAA receptor 1 subunit
To examine further the role of RACK-1 binding to
GABAA receptors, we attempted to block this
interaction by using a synthetic peptide corresponding to the RACK-1
binding site (Pep-GC; RHGVPGKGRI) that we identified within the
intracellular domain of the receptor 1 subunit (Fig. 1). GST- 1
was exposed to rat brain extract and then incubated with either the
Pep-GC or a scrambled version of the same peptide (Pep-SC; RRGGGIKPVH).
Inclusion of the RACK-1 peptide Pep-GC at 50 nM clearly
abolished the binding of RACK-1 to GST- 1 (Fig.
2A) without affecting
the level of PKC binding to GST- 1 (Fig. 2A). The
scrambled peptide did not alter the binding of either RACK-1 or PKC to
GST- 1 (Fig. 2A).

View larger version (27K):
[in this window]
[in a new window]
|
Figure 2.
Disrupting RACK-1 binding to the
GABAA 1 subunit receptor reduces PKC phosphorylation of
the receptor. A, Pep-GC prevents RACK-1 binding to the
intracellular domain of the GABAA receptor 1 subunit.
GST- 1 was exposed to adult rat brain extracts and then alone
(lane 1), with 50 nM Pep-SC (lane
2), or with 50 nm Pep-GC (lane 3). Lane
4 represents 10% of the input that was used. Bound material
was blotted with an anti-PKC- II antibody (top) or
anti-RACK-1 (bottom). B, GST- 1 fusion
protein was phosphorylated by associated PKC activity on S409. GST- 1
(lanes 1-4) or GST- 1S409A
(lane 5) was exposed to adult rat brain extracts. After
extensive washing, the fusion proteins were subjected to kinase assays
alone (lanes 1, 4, 5) or in the presence of either 0.1 µM (lane 2) or 0.01 µM
(lane 3) PKC inhibitor peptide (PKC19-36).
C, Pep-GC reduced the phosphorylation of GST- 1.
GST- 1 was exposed to brain lysate and then incubated with 50 nM Pep-GC (lane 2), 50 nM Pep-SC
(lane 3), or buffer alone (lane 1). After
extensive washing, the bound material was subjected to in
vitro kinase assays. The reaction products were separated by
SDS-PAGE and analyzed by autoradiography (top). Also
shown is a Coomassie stain of the fusion proteins to demonstrate equal
loading (bottom). The data are representative of four
independent experiments. D, The changes in
phosphorylation of the 1 subunit in B were
quantitated by the use of a PhosphorImager. The effects of Pep-GC
and Pep-SC were calculated as the change relative to the untreated
sample. Pep-GC produced a 27 ± 2.1% decrease in phosphorylation
of GST- 1 compared with control (p > 0.001; Student's t test; n = 4).
E, Binding of PKC to GST- 1 was modulated via
phosphorylation of S409. GST- 1 (lanes 1, 2) or GST
alone (lanes 3, 4) was subjected to in
vitro kinase assays with purified PKA with (+) or without ( )
ATP before exposure to adult rat brain. The final stoichiometry of
phosphorylation of the GST- 1 in these experiments was 0.8 ± 0.05 mol/mol. Samples were washed and separated by SDS-PAGE.
Immunoblotting with an anti-PKC- II antibody was used to detect the
association of PKC. The data are representative of five independent
experiments. The average binding of PKC to phosphorylated GST- 1 was
decreased by 90 ± 5% of control (p > 0.001; Student's t test; n = 5).
|
|
To measure whether PKC associated with GST- 1 is
catalytically active, we used in vitro kinase assays. This
approach revealed that GST- 1 was phosphorylated in these assays and
that phosphorylation was blocked completely by a specific PKC inhibitor
(Fig. 2B), confirming our immunoblotting approaches
(Fig. 2A). Moreover, the sole site of phosphorylation
for PKC in GST- 1 is S409 (Moss et al., 1992a ,b ; Krishek et
al., 1994 ; Brandon et al., 1999 ) because GST- 1S409A was not phosphorylated
significantly in this assay (Fig. 2B), but PKC can
still bind to this protein (Fig. 1D). Together, these results confirm that activated PKC interacts with the intracellular domain of receptor subunits in agreement with previous observations (Moss et al., 1992a ,b ; Krishek et al., 1994 ; Brandon et al.,
1999 ). To test the importance of RACK-1 in facilitating PKC-mediated phosphorylation of GST- 1, we exposed material associating with this
protein from brain extracts to Pep-GC or the control peptide Pep-SC.
After extensive washing, the effects of these agents on PKC-mediated
phosphorylation of GST- 1 were analyzed. Pep-GC produced a highly
significant 30 ± 2.1% decrease compared with control (p > 0.001; Student's t test;
n = 4) in the PKC-mediated phosphorylation of GST- 1
(Fig. 2C,D). In contrast, Pep-SC was without effect on
PKC-dependent phosphorylation of GST- 1 (Fig.
2B,C).
Together, our results reveal that Pep-GC
specifically blocks the binding of RACK-1 to GST- 1 without having
any effect on the level of PKC binding. Moreover, the loss of RACK-1
binding correlates with a reduction in the activity of PKC bound to the GABAA receptor. Therefore, our results
demonstrate that RACK-1 and PKC bind to differing but adjacent sites on
the GABAA receptor 1 subunit and suggest that
the role of RACK-1 at GABAA receptors is not
simply to target PKC activity to these proteins (Ron et al., 1999 ;
Jaken and Parker, 2000 ) but to potentiate receptor phosphorylation by
associated PKC.
PKC, but not RACK-1, binding to the GABAA receptor 1
subunit is modulated via the phosphorylation of the PKC binding
site
Inhibiting RACK-1 binding to the intracellular domain of the
GABAA receptor 1 subunit does not appear to
modify PKC binding. Although the binding of PKC to the 1 subunit
residues 405-415 did not require the presence of S409 (Fig.
1B,C), the possibility that phosphorylation of this
residue may modulate PKC binding still remains. Therefore, we tested
this possibility by using fusion proteins that had been phosphorylated
in vitro by PKA before exposure to neuronal lysates. We were
unable to test the effect of PKC phosphorylation, because purified PKC
would bind to the fusion proteins and interfere with additional
analysis. Therefore, GST- 1 was phosphorylated via PKA, which also
phosphorylates S409 (Moss et al., 1992a ,b ), without binding to
GABAA receptor subunits (N. J. Brandon
and S. J. Moss, unpublished observation), allowing us to
investigate the phospho-dependence of PKC binding to GST- 1.
Phosphorylation of GST- 1 on S409 to a final stoichiometry of
0.8 ± 0.05 mol of phosphate/mol of protein (n = 4) by PKA significantly reduces the level of PKC binding in an
ATP-dependent manner (Fig. 2E) by 90 ± 5%
(p > 0.001; Student's t test;
n = 5). In contrast, the binding of RACK-1 to the 1
subunit intracellular domain was independent of the phosphorylation
status of S409 (data not shown). Therefore, it appears evident that PKC
and RACK-1 binding to GABAA receptors can be
regulated differentially via the phosphorylation of S409 within the
binding site for PKC on the 1 subunit.
Complexes of RACK-1, PKC, and GABAA receptors are found
in neurons and HEK 293 cells
To examine the association PKC and RACK-1 with
GABAA receptors of defined subunit composition
and functional properties, we used transient expression of recombinant
receptors in HEK 293 cells (Pritchett et al., 1989 ; Rabow et al., 1995 ;
Connolly et al., 1996 ). HEK 293 cells expressing
GABAA receptors composed of 1/ 1 subunits
were labeled with [35S]methionine and
immunoprecipitated with anti- 1/ 3. This antiserum precipitated two
prominent bands of 52 and 58 kDa (Fig.
3A) that were not present in
untransfected cells or precipitated with control IgG and thus represent
the 1 and 1 subunits, respectively, as demonstrated previously
(Moss et al., 1992a ,b ; Krishek et al., 1994 ). Precipitated
material also was tested for the presence of RACK-1 and PKC. Endogenous
RACK-1 and PKC clearly coimmunoprecipitated with anti- 1/ 3 (Fig.
3B), but not with control IgG as measured by immunoblotting.
Identical results were obtained when immunoprecipitation was performed
with antisera against the 1 subunit.

View larger version (30K):
[in this window]
[in a new window]
|
Figure 3.
GABAA receptors form a complex with
PKC and RACK-1 in HEK 293 cells and in the brain. A,
Immunoprecipitation of GABAA receptors from HEK 293 cells.
Transfected cells expressing the receptor 1/ 1 subunits
(lanes 1, 2) or control mock-transfected cells
(lane 3) were labeled with
[35S]methionine and lysed. Cell extracts then were
immunoprecipitated with anti- 1/ 3 antisera (lanes 1, 3) or control nonimmune IgG (lane 2).
Precipitated material was separated by SDS-PAGE, and the receptors were
visualized by autoradiography. B, Coimmunoprecipitation
of RACK-1 and PKC with GABAA receptors from HEK 293 cells.
HEK 293 cells expressing receptor 1/ 1 subunits (lanes 1, 2) or mock-transfected cells (lane 3) were
immunoprecipitated with anti- 1/ 3 (lanes 1, 3) or
nonimmune IgG (lane 2). Cell extracts were immunoblotted
with an anti-PKC- II antibody (top) or with an
antibody specific for RACK-1 (bottom). Lane
4 represents 20% of the material that was used for the
immunoprecipitations. C, PKC and RACK-1 form complexes
with GABAA receptors in vivo. Adult rat
brain extracts (1 mg of total protein, lanes 1, 3; 5 mg
of total protein, lanes 2, 4) were subject to
immunoprecipitation with either anti-GABAA 1/ 3
antisera (lanes 3, 4) or nonimmune IgG
(lanes 1, 2). Precipitated material was separated by
SDS-PAGE; then immunoblotting was performed with an antibody against
PKC- II (top) or with anti-RACK-1 antibody
(bottom).
|
|
To determine whether RACK-1 and PKC are associated with neuronal
GABAA receptors, we again used
immunoprecipitation, followed by Western blotting. PKC and RACK-1
coimmunoprecipitate with GABAA receptor 1/ 3
subunits from adult rat brain with the use of antisera against the
receptor 1/ 3 subunits (Brandon et al., 1999 ), but not with
control IgG (Fig. 3D). Therefore, these observations demonstrate that complexes of GABAA receptors
RACK-1 and PKC are found in neurons and heterologous systems.
PKC modulation of GABAA receptors via direct
phosphorylation of receptor subunits is enhanced by RACK-1
The effects of RACK-1 on GABAA receptor
modulation by PKC activity were examined first, by using patch-clamp
recording, in HEK 293 cells expressing receptors composed of 1 1
subunits, which are modulated negatively by PKC activity (Krishek et
al., 1994 ). This subunit combination was chosen because it represents the simplest combination of GABA-sensitive functional receptors that
are modulated by direct PKC-mediated phosphorylation of a single
biochemically defined phosphorylation site within the 1 subunit.
Control GABA-activated currents were stable for 50 min after formation
of the whole-cell recording mode. Activation of PKC with the phorbol
ester PMA, externally perfused via the Krebs' solution, reduced the
peak amplitude of the GABA-activated current by up to 46 ± 5%
(Fig. 4A,E), which was
mediated via the phosphorylation of S409 by PKC in the 1 subunit
(Krishek et al., 1994 ). Control currents are well maintained in these
cells, with no rundown evident after 50 min of recording (Krishek et
al., 1994 ) To disrupt the interaction between RACK-1 and
GABAA receptors, we included GST fusion proteins
encoding parts of the intracellular domain of the receptor 1 subunit
in the patch pipette solution to compete for RACK-1 binding. In the
presence of the GST fusion protein 366-404, which contains the RACK-1
binding site, PKC-dependent regulation of GABAA
receptor function is blocked almost totally (Fig.
4B,E). In contrast, fusion proteins that do not
contain the RACK-1 binding site (either residues 302-365 or 366-394)
(Fig. 4C,E and D,E) or GST alone (data not shown)
were without effect. To analyze further the role of RACK-1 in
PKC-dependent regulation of GABAA receptor
function, we used the decapeptide that blocked the binding of RACK-1 to
the receptor 1 subunit Pep-GC. Inclusion of Pep-GC peptide in the
patch pipette significantly blocked the reduction in peak amplitude of
the GABA-activated current after PKC activation with 500 nM PMA (Fig. 5),
similar to our observations that used the GST- 1 366-404 fusion
protein (Fig. 4B,E). In contrast, the
control-scrambled peptide, Pep-SC, did not reduce PKC-dependent inhibition of GABA-activated currents (Fig. 5). As an additional control for any potential background effects of Pep-GC that are not
related to the PKC-dependent phosphorylation of S409, we assessed the
activity of this peptide in HEK 293 cells coexpressing the GABAA receptor 1 subunit and a mutant 1
subunit in which S409 had been replaced by an alanine residue
( 1S409A; data not shown). In contrast
to cells expressing wild-type receptors, PKC activation had no effect
on the GABA-activated response in cells expressing receptors composed
of 1 1S409A subunits. Moreover,
Pep-GC had no significant functional effect on these receptors when
included in the patch pipette, suggesting that for the wild-type
receptor it was the prevention of RACK-1 binding to the 1 subunit
that caused the reduction in GABA current inhibition after PKC
activation (data not shown). Together, our results illustrate that
RACK-1 binding to GABAA receptors composed of
1/ 1 subunits facilitates the PKC-dependent regulation of receptor
function via phosphorylation of S409 in the 1 subunit.

View larger version (26K):
[in this window]
[in a new window]
|
Figure 4.
PKC modulation of GABAA receptor
activation is dependent on RACK-1. GABA-activated currents were
recorded under whole-cell voltage clamp at 25°C from single HEK 293 cells expressing 1 1 GABAA receptors at a holding
potential of 50 mV. GABA (10 µM) was used to activate a
near-maximal response and was applied for the durations indicated at 5, 10, 15, and 25 min after formation of the whole-cell recording mode (P + t min) either in the absence (solid
lines) or presence (broken lines) of 100 nM PMA. The patch pipette solution contained the control or
unsupplemented solution (A; also see Materials and
Methods) or incorporated a GST fusion protein of the intracellular
domain of the 1 subunit, including the RACK-1 binding site (120 µg/ml; B) or the GST fusion proteins, but not
including the RACK-1 binding site, sequence 302-365
(C) and sequence 366-394
(D) at 200 µg/ml. The inhibition of peak
GABA-activated currents caused by PKC activation for each protocol is
indicated in E. The filled bar (mean ± SEM) represents the control 10 µM GABA-activated
current at P + 1 min to which all subsequent responses to GABA in each
cell were normalized. The open bar (+PMA) and
shaded bars (patch pipette solution supplementation with
Pep-GC, GST-320-365, or GST-366-394) represent current amplitudes
measured at P + 30 min in n = 4-5 cells. The
horizontal broken lines indicate, for reference, the
mean inhibition induced by 100 nM PMA in control HEK 293 cells recorded with unsupplemented patch pipette solution (E,
top). The time calibration is 5 sec, and the membrane current
calibrations are 100 pA (A) and 300 pA
(B-D). *Significantly different from control
(p > 0.01; Student's t
test; n = 4).
|
|

View larger version (17K):
[in this window]
[in a new window]
|
Figure 5.
Time dependence of RACK-1 peptides in modulating
GABA-activated currents. HEK 293 cells expressing 1 1
GABAA receptor subunits were exposed to 0.5 µM PMA at 25°C after the formation of the whole-cell
recording mode at 50 mV holding potential. The patch pipette solution
was the control solution (open circles), or the solution
was supplemented with 120 µg/ml RACK-1 binding site peptide (Pep-GC;
filled circles) or 120 µg/ml of a scrambled version of
the same peptide (Pep-SC; open squares). The
GABA-activated currents were normalized to the initial currents
recorded after formation of the whole-cell recording (= 1), and PMA was
applied at P + 10 min. *Significantly different from cells treated with
phorbol esters alone (p > 0.05; Student's
t test; n = 4).
|
|
Regulation of GABAA receptor function by PKC signaling
pathways in neurons is enhanced by RACK-1
To study the role of RACK-1 in the functional modulation of
neuronal GABAA receptors, we used cultured
superior cervical ganglion neurons (SCG). This preparation was studied
because of its relative low diversity of neuronal cell types (Lees,
1986 ). Moreover, we have established that zinc-sensitive
GABAA receptor function in these neurons can be
inhibited by PKC activity, suggesting a significant presence of
receptors containing the 1 subunits (Moss et al., 1992a ,b ;
Krishek et al., 1994 ). Control whole-cell voltage-clamp recordings
revealed that GABA-induced responses were stable for up to 30 min
without any significant rundown in the response amplitude (Fig.
6). Inclusion of 500 nM PMA
in the Krebs' solution produced a large reduction in the response
amplitude of, on average, 40% (Fig. 6), as described previously, an
effect that can be blocked completely by specific PKC inhibitors
(Krishek et al., 1994 ). To test the role of RACK-1 in the PKC-dependent
modulation of receptor function, we made recordings from SCG neurons
with either Pep-GC or Pep-SC included in the patch pipette. In the
presence of Pep-GC the effect of PKC activity on GABA-activated
currents was reduced significantly to an inhibition of 10% compared
with that observed in the presence of PMA alone (Fig. 6). In contrast, the scrambled peptide Pep-SC had no effect on PKC-mediated
inhibition of GABA-activated currents (Fig. 6). Therefore, our results
illustrate that RACK-1 facilitates GABAA receptor
functional modulation in SCG neurons by PKC activity.

View larger version (21K):
[in this window]
[in a new window]
|
Figure 6.
Interaction of RACK-1 with PKC modulation of
GABA-activated currents in sympathetic neurons. The bar graph
represents GABA-activated currents recorded at 25°C from cultured rat
sympathetic ganglionic neurons [10 d in vitro (10 DIV)] at 50 mV holding potential. Peak current amplitudes were
measured to 5 µM GABA at P + 25 min after formation of
the whole-cell recording mode and were normalized to the currents
recorded initially on achieving the whole-cell mode. The neurons were
subjected to the following conditions: GABA-activated currents were
recorded with control pipette solution (filled
bar) and also recorded from neurons exposed to 100 nM PMA by using control pipette solution (open
bar) or by using a patch pipette solution supplemented either
with 120 µg/ml RACK-1 binding site peptide (Pep-GC; shaded
bar) or with 120 µg/ml of the scrambled version of the RACK-1
peptide (Pep-SC; hatched bar). *Significantly different
from cells treated with phorbol esters alone (Student's
t test; p > 0.05;
n = 4).
|
|
To analyze further the involvement of RACK-1 in the modulation of
GABAA receptors by PKC activity in a more
physiological context, we examined the effects of mAChR activation on
GABAA receptor function. SCG neurons
predominately express the M1 mAChR subtype, which
mediates many of its downstream effects via the activation of PKC
(Lees, 1986 ; Brown et al., 1997 ; Haley et al., 1998 ). Activation of
mAChRs with 1 µM muscarine in SCG neurons produced a
significant decrease in GABA-mediated currents similar in onset and
magnitude to those seen on the direct activation of PKC. To establish
whether this effect was mediated by PKC activity, we made recordings
with a patch pipette solution containing a specific peptide inhibitor
of PKC (PKC19-36). This inhibitor completely
blocked the effects of mAChR activation on GABA-mediated currents
(10 ± 5% inhibition), demonstrating that mAChR modulation of
GABAA receptor function is dependent on the
activation of PKC (Fig. 7). To ascertain
the role of RACK-1 in mAChR modulation of GABAA
receptor function, we included in the patch pipette solution Pep-GC,
which blocks the binding of RACK-1 to the GABAA
receptor 1 subunit. Pep-GC significantly reduced the effects of
mAChR activation on GABA-mediated currents to 20 ± 5% inhibition
(Fig. 7). The scrambled peptide was without effect on
muscarine-dependent inhibition of GABA-mediated currents.

View larger version (30K):
[in this window]
[in a new window]
|
Figure 7.
mAChR activation modulates GABA-induced currents
via a RACK-1-dependent mechanism. GABA-activated currents are
represented as a bar graph recorded at 25°C from cultured sympathetic
neurons at 6 DIV and at 30 min after the initiation of whole-cell
recording at 50 mV holding potential. All currents were normalized to
the response to 5 µM GABA recorded after formation of the
whole-cell recording mode and represent the mean ± SEM.
GABA-activated currents were recorded in control Krebs' solution with
normal pipette solution (filled bar) and also
after treatment with 1 µM muscarine (musc)
to activate muscarinic acetylcholine receptors. The muscarine-treated
cells were recorded with normal pipette solution (open
bar) and after supplementation of the pipette solution with
either Pep-GC (shaded bar) at 200 µg/ml or PKC
inhibitor peptide (hatched bar) at 15 µg/ml.
*Significantly different from cells treated with muscarine alone
(Student's t test; p > 0.05;
n = 4).
|
|
To determine whether mAChR activation can modulate
GABAA receptor subunit phosphorylation, we
used a phospho-specific antiserum raised to bind specifically to
di-phospho S408/S409 in the 3 subunit, both of which are
phosphorylated by PKC activity in neurons (McDonald et al., 1998 ;
Jovanovic et al., 2001 ). Furthermore, the 3 subunit, like the 1
subunit, can bind directly both RACK-1 and PKC (Brandon et al., 1999 ).
For these studies we used cultured cortical neurons, because it is
impossible to produce sufficient numbers of SCG neurons in culture for
biochemical experiments. Activation of mAChRs in cortical neurons by 1 µM muscarine produced a sixfold enhancement in the
phosphorylation state of S408/S409 residues in the 3 subunit
compared with control untreated samples (Fig.
8); the effects of muscarine were
transient, and S408/S409 phosphorylation returned to basal levels after
30 min of treatment. Importantly, the enhanced phosphorylation of the
3 subunit by muscarine was blocked completely by calfostin, a
specific PKC inhibitor. Therefore, it is apparent that
GABAA receptors are phosphorylated on
functionally relevant residues with the activation of mAChRs in neurons
by a PKC-dependent process. The transient nature of mAChR-induced
GABAA receptor phosphorylation is interesting and
may arise from mAChR desensitization. However, the kinetics of receptor
phosphorylation observed in cortical neurons cannot be compared
directly with the electrophysiological experiments in SCG neurons
because of the differences in the incubation temperature of 37 or
25°C used, respectively, in these experiments.

View larger version (44K):
[in this window]
[in a new window]
|
Figure 8.
Muscarinic acetylcholine receptor activation
facilitates PKC-dependent phosphorylation of GABAA receptor
subunits. A, The level of phosphorylation of
GABAA receptor 3 subunit in cortical neurons (8 DIV)
under basal conditions (lane 1) or treated with
muscarine (1 µM) for 10 min (lane 2), 20 min (lane 3), or 30 min (lane 4)
or with muscarine for 20 min in the presence of the PKC inhibitor
calfostin C (500 nM; lane 5) was assessed by
SDS-PAGE and immunoblotting with either P- 3 408/409 antibody (UCL39;
1:50; top blot) or 3 antibody (Tot- 3; 1:200;
bottom blot), followed by incubation with
125I-anti-rabbit secondary antibody. B, The
level of 3 subunit phosphorylation on S408/S409 was quantitated with
a PhosphorImager. The bar graph represents the levels of 3 subunit
phosphorylation on S408/S409 calculated for each treatment as a
percentage of control (untreated) normalized for total 3 subunit
levels under the same experimental conditions. Similar results were
seen in three separate experiments.
|
|
Together, our observations suggest a central role for RACK-1 in
facilitating PKC-dependent phosphorylation and functional modulation of
GABAA receptors with the activation of mAChRs in neurons.
 |
DISCUSSION |
Targeting of protein kinase activity to ion channels is emerging
as a critical factor in controlling their functional modulation in
addition to neuronal activity (Fraser and Scott, 1999 ; Levitan, 1999 ).
In the case of nicotinic acetylcholine or ionotropic glutamate receptors, direct interactions of receptor subunits with protein kinases or interactions with scaffold molecules such as A
kinase-anchoring proteins known to bind PKA holoenzyme are believed to
facilitate the phosphorylation of these receptors (Swope and Huganir,
1993 ; Yu et al., 1997 ; Fraser and Scott, 1999 ; Levitan, 1999 ; Westphal et al., 1999 ). In contrast, the mechanisms that control the targeting of signaling molecules to GABAA receptors to
facilitate subunit phosphorylation and receptor functional modulation
remain unknown.
To address this issue, we have investigated the functional significance
of the interactions between PKC isoforms and RACK-1 with
GABAA receptors (Brandon et al., 1999 ). The
function of RACK-1 is unclear, but this protein has been implicated in
the subcellular targeting of and II PKC isoforms (Ron et al.,
1999 ; Jaken and Parker, 2000 ). This is based on observations in cell
lines in which the activation of PKC, via the dopamine D2 receptor,
results in the translocation of both PKC and RACK-1 to the same sites in the plasma membrane (Ron et al., 1999 ). RACK-1 also can interact with a number of other proteins, including integrin subunits, phosphodiesterase isoforms, and Src (Chang et al., 1998 ; Liliental and
Chang, 1998 ; Yarwood et al., 1999 ). Here we have established that
RACK-1 and PKC isoforms bind independently but directly to adjacent
sites within the intracellular domain of the
GABAA receptor 1 subunit. PKC bound to
residues that incorporate the only PKC phosphorylation site in this
protein, S409. Although binding affinity was not dependent on the
identity of this phospho-acceptor residue (Moss et al., 1992a ,b ;
Krishek et al., 1994 ), it was shown to decrease with the
phosphorylation of S409, which implies that covalent modification of
receptor structure in this intracellular domain is important for kinase
association. In contrast, RACK-1 bound to residues N-terminal to the
PKC binding site and was affected neither by the presence of S409 nor
by its phosphorylation status, strongly suggesting that the interaction
of RACK-1 and PKC with GABAA receptors may be
regulated differentially. Importantly, the specific binding of RACK-1,
but not PKC, to the 1 subunit could be blocked by using a peptide
corresponding to the RACK-1 binding site within this protein.
Therefore, our results reveal that RACK-1 and PKC bind independently to
the GABAA receptor 1 subunit, demonstrating
that RACK-1 does not simply facilitate the targeting of and II
PKC isoforms to GABAA receptors. Interestingly, the residues that mediate RACK-1 and PKC binding are partially conserved in all receptor subunits (Ymer et al., 1989 ; Rabow et
al., 1995 ). Given that most GABAA receptor
subtypes incorporate subunit isoforms (Ymer et al., 1989 ; Benke et
al., 1994 ; Rabow et al., 1995 ; Connolly et al., 1996 ), this suggests an
intimate association of most populations of neuronal
GABAA receptors with RACK-1 and PKC isoforms.
Blocking RACK-1 binding significantly reduced PKC-mediated
phosphorylation of the 1 subunit on S409 without affecting PKC
binding and also the inhibitory effect of PKC on GABA-activated
membrane currents recorded from both recombinant and neuronal
GABAA receptors. This is consistent with a role
for RACK-1 in potentiating the activity of PKC bound to the 1
subunit and in facilitating phosphorylation rather than simply playing a role in PKC anchoring, especially because PKC- II and RACK-1 can
bind in the absence of GABAA receptor subunits
(Brandon et al., 1999 ; Ron et al., 1999 ; Jaken and Parker, 2000 ). The
precise mechanism of PKC-dependent modulation on
GABAA receptor function is complex, with effects
on both receptor internalization and channel kinetics being reported
(for review, see Brandon et al., 2000a ). PKC can modulate
GABAA receptor gating in neurons apparently without affecting cell surface stability for receptor subtypes containing 2/ 3 subunits (Brandon et al., 2000a ,b ). In agreement with this, the activity of GABAA receptors
expressed in Xenopus oocytes or HEK 293 cells are modulated
by PKC activity via direct phosphorylation of intracellular serine
residues within the receptor and 2 subunits (Brandon et al.,
2000a ; Moss and Smart, 2001 ). However, in recombinant systems PKC
activity also appears to modulate GABAA receptor
cell surface stability via a mechanism that is independent of direct
receptor phosphorylation (Chapell et al., 1998 ; Brandon et al.,
2000a ).
RACK-1 is also of relevance to PKC regulation of neuronal
GABAA receptors. In SCG neurons, blocking RACK-1
binding dramatically reduced the PKC modulation of
GABAA receptor function (Krishek et al., 1994 ;
Brandon et al., 2000a ). We also established by using SCG neurons that
GABAA receptor function could be modulated by the
activation of mAChRs via a PKC-dependent pathway, which inhibited receptor function. Importantly, this endogenous G-protein-coupled receptor-based mechanism in SCG neurons for the regulation of GABAA receptor function was also dependent on
RACK-1 binding to receptor subunits. Interestingly RACK-1 also has been
implicated in PKC-dependent modulation of GABAA
receptor function by 5-HT2 receptor activation in
cortical neurons (Feng et al., 2001 ). Interestingly, in cortical
neurons mAChR activation enhances PKC-dependent phosphorylation of the
GABAA receptor 3 subunit on residues
S408/S409, key sites for receptor functional modulation (Brandon et
al., 2000a ), suggesting that mAChR modulation of
GABAA receptor function may be attributable to
direct modification of receptor phosphorylation. However, to confirm
this awaits the production of mutated mouse lines in which the
phosphorylation of individual subunits has been ablated via homologous recombination.
In addition to binding PKC and the GABAA receptor
subunits, RACK-1 is also able to bind the tyrosine kinase Src
(Chang et al., 1998 ). Interestingly, GABAA
receptors are modulated via direct tyrosine phosphorylation by Src of
sites primarily within the 2 subunit, and this kinase has been shown
recently to bind to receptor and 2 subunits (Moss et al., 1995 ;
Brandon et al., 2001 ). Therefore, RACK-1 also may play a central role
in targeting Src to GABAA receptors to facilitate
receptor tyrosine phosphorylation (Moss et al., 1995 ; Brandon et al.,
2001 ).
Our results have revealed an important role for RACK-1 in
the phosphorylation and functional modulation of
GABAA receptors with the activation of
neurotransmitter receptors that signal via PKC-dependent pathways.
Therefore, RACK-1 may facilitate functional cross talk between
G-protein-coupled receptor-signaling pathways and
GABAA receptors. Because
GABAA receptors are critical mediators of
synaptic inhibition, RACK-1/PKC-dependent phosphorylation of these
receptors and its functional consequences may have profound effects on
neuronal excitability.
 |
FOOTNOTES |
Received Jan. 22, 2002; revised April 10, 2002; accepted May 10, 2002.
This work was supported by the Wellcome Trust and the Medical Research Council.
Correspondence should be addressed to Dr. Stephen J. Moss, Medical
Research Council, Laboratory of Molecular Cell Biology, University
College London, Gower Street, London WC1E 6BT, UK. E-mail:
steve.moss{at}ucl.ac.uk.
 |
REFERENCES |
-
Benke D,
Fritschy JM,
Trzeciak A,
Bannwarth W,
Mohler H
(1994)
Distribution, prevalence, and drug binding profile of
-aminobutyric acid type A receptor subtypes differing in the -subunit variant.
J Biol Chem
269:27100-27107[Abstract/Free Full Text]. -
Billups D,
Hanley JG,
Orme M,
Attwell D,
Moss SJ
(2000)
GABAC receptor sensitivity is modulated by interaction with MAP1B.
J Neurosci
20:8643-8650[Abstract/Free Full Text].
-
Bonnert TP,
McKernan RM,
Farrar S,
le Bourdelles B,
Heavens RP,
Smith DW,
Hewson L,
Rigby MR,
Sirinathsinghji DJ,
Brown N,
Wafford KA,
Whiting PJ
(1999)
Theta, a novel
-aminobutyric acid type A receptor subunit.
Proc Natl Acad Sci USA
96:9891-9896[Abstract/Free Full Text]. -
Brandon NJ,
Uren JM,
Kittler JT,
Wang H,
Olsen R,
Parker PJ,
Moss SJ
(1999)
Subunit-specific association of protein kinase C and the receptor for activated C kinase with GABA type A receptors.
J Neurosci
19:9228-9234[Abstract/Free Full Text].
-
Brandon NJ,
Smart TG,
Moss SJ
(2000a)
Regulation of GABAA receptors by protein phosphorylation.
In: GABA in the nervous system, the view at 50 years (Martin DL,
Olsen RL,
eds), pp 191-206. Baltimore: Williams & Wilkins.
-
Brandon NJ,
Delmas P,
Kittler JT,
McDonald BJ,
Sieghart W,
Brown DA,
Smart TG,
Moss SJ
(2000b)
GABAA receptor phosphorylation and functional modulation in cortical neurons by a protein kinase C-dependent pathway.
J Biol Chem
275:38856-38862[Abstract/Free Full Text].
-
Brandon J,
Delmas P,
Hill J,
Smart TG,
Moss SJ
(2001)
Constitutive tyrosine phosphorylation of the GABAA receptor
2 subunit in rat brain.
Neuropharmacology
41:745-752[Web of Science][Medline]. -
Brown DA,
Abogadie FC,
Allen TG,
Buckley NJ,
Caulfield MP,
Delmas P,
Haley JE,
Lamas JA,
Selyanko AA
(1997)
Muscarinic mechanisms in nerve cells.
Life Sci
60:1137-1144[Web of Science][Medline].
-
Browning MD,
Bureau M,
Dudek EM,
Olsen RW
(1990)
Protein kinase C and cAMP-dependent protein kinase phosphorylate the
subunit of the purified GABAA receptor.
Proc Natl Acad Sci USA
87:1315-1318[Abstract/Free Full Text]. -
Brunig I,
Sommer M,
Hatt H,
Bormann J
(1999)
Dopamine receptor subtypes modulate olfactory bulb GABAA receptors.
Proc Natl Acad Sci USA
96:2456-2460[Abstract/Free Full Text].
-
Chang BY,
Conroy KB,
Machleder EM,
Cartwright CA
(1998)
RACK-1, a receptor for activated C kinase and a homolog of the beta subunit of G-proteins, inhibits activity of Src tyrosine kinases and growth of NIH 3T3 cells.
Mol Cell Biol
18:3245-3256[Abstract/Free Full Text].
-
Chapell R,
Bueno OF,
Alvarez-Hernandez X,
Robinson LC,
Leidenheimer NJ
(1978)
Activation of protein kinase C induces
-aminobutyric acid type A receptor internalization in Xenopus oocytes.
J Biol Chem
273:32595-32601[Abstract/Free Full Text]. -
Connolly CN,
Krishek BJ,
McDonald BJ,
Smart TG,
Moss SJ
(1996)
Assembly and cell surface expression of heteromeric and homomeric GABAA receptors.
J Biol Chem
271:89-96[Abstract/Free Full Text].
-
Davies PA,
Hanna MC,
Hales TG,
Kirkness EF
(1997)
Insensitivity to anaesthetic agents conferred by a class of GABAA receptor subunit.
Nature
385:820-823[Medline].
-
Feng J,
Cai X,
Zhao J,
Yan Z
(2001)
Serotonin receptors modulate GABAA receptor channels through activation of anchored protein kinase C in prefrontal cortical neurons.
J Neurosci
21:6502-6511[Abstract/Free Full Text].
-
Fraser IDC,
Scott JD
(1999)
Modulation of ion channels: a current view of AKAPs.
Neuron
23:423-426[Web of Science][Medline].
-
Haley JE,
Abogadie FC,
Delmas P,
Dayrell M,
Vallis Y,
Milligan G,
Caulfield MP,
Brown DA,
Buckley NJ
(1998)
The
subunit of Gq contributes to muscarinic inhibition of the M-type potassium current in sympathetic neurons.
J Neurosci
18:4521-4523[Abstract/Free Full Text]. -
Jaken S,
Parker PJ
(2000)
Protein kinase C binding partners.
BioEssays
22:245-254[Web of Science][Medline].
-
Jovanovic JN,
Kittler JT,
Brandon NJ,
Sieghart W,
Moss SJ
(2001)
Characterization of the specificity in situ of the phosphorylation state-specific antibody for GABAA receptor
3 subunit.
Soc Neurosci Abstr
27:522.1. -
Kellenberger S,
Malherbe P,
Sigel E
(1992)
Function of the
1 2 2S -aminobutyric acid type A receptor is modulated by protein kinase C via multiple phosphorylation sites.
J Biol Chem
267:25660-25663[Abstract/Free Full Text]. -
Krishek BJ,
Xie X,
Blackstone C,
Huganir RL,
Moss SJ,
Smart TG
(1994)
Regulation of GABAA receptor function by protein kinase C phosphorylation.
Neuron
12:1081-1095[Web of Science][Medline].
-
Lees GM
(1986)
Anatomy, histology, and electron microscopy of sympathetic, parasympathetic, and enteric neurons.
In: Autonomic and enteric ganglia. Transmission and its pharmacology (Karczmar AG,
Koketsu K,
Nishi S,
eds), pp 27-60. New York: Plenum.
-
Levitan IB
(1999)
Modulation of ion channels by protein phosphorylation. How the brain works.
Adv Second Messenger Phosphoprotein Res
33:3-22[Web of Science][Medline].
-
Liliental J,
Chang DD
(1998)
RACK-1, a receptor for activated protein kinase C, interacts with integrin
subunit.
J Biol Chem
273:2379-2383[Abstract/Free Full Text]. -
Lin Y-F,
Angelotti TP,
Dudek EM,
Browning MD,
Macdonald RL
(1996)
Enhancement of recombinant
1 1 2L GABAA receptor whole-cell currents by protein kinase C is mediated through phosphorylation of both 1 and 2L subunits.
Mol Pharmacol
50:185-195[Abstract]. -
McDonald BJ,
Moss SJ
(1997)
Conserved phosphorylation of the intracellular domains of GABAA receptor
2 and 3 subunits by cAMP-dependent protein kinase, cGMP-dependent kinase, protein kinase C, and Ca2+/calmodulin type II-dependent protein kinase.
Neuropharmacology
36:1377-1385[Web of Science][Medline]. -
McDonald BJ,
Amato A,
Connolly CN,
Benke D,
Moss SJ,
Smart TG
(1998)
Adjacent phosphorylation sites on GABAA receptor
subunits determine regulation by cAMP-dependent protein kinase.
Nat Neurosci
1:23-28[Web of Science][Medline]. -
Moss SJ,
Smart TG
(2001)
Constructing inhibitory synapses.
Nat Neurosci Rev
2:241-250.
-
Moss SJ,
Doherty CA,
Huganir RL
(1992a)
Identification of the cAMP-dependent protein kinase and protein kinase C phosphorylation sites within the major intracellular domains of the
1, 2S, and 2L subunits of the GABAA receptor.
J Biol Chem
267:14470-14476[Abstract/Free Full Text]. -
Moss SJ,
Smart TG,
Blackstone CD,
Huganir RL
(1992b)
Functional modulation of GABAA receptors by cAMP-dependent protein phosphorylation.
Science
257:661-665[Abstract/Free Full Text].
-
Moss SJ,
Gorrie GH,
Amato A,
Smart TG
(1995)
Modulation of GABAA receptor function by tyrosine phosphorylation.
Nature
377:344-348[Medline].
-
Poisbeau P,
Cheney MC,
Browning MD,
Mody I
(1999)
Modulation of synaptic GABAA receptor function by PKA and PKC in adult hippocampal neurons.
J Neurosci
19:674-683[Abstract/Free Full Text].
-
Pritchett DB,
Sontheimer H,
Shivers BD,
Ymer S,
Kettenmann H,
Schofield PR,
Seeburg PH
(1989)
Importance of a novel GABAA receptor subunit for benzodiazepine pharmacology.
Nature
338:582-585[Medline].
-
Rabow LE,
Russek SJ,
Farb DH
(1995)
From ion currents to genomic analysis: recent advances in GABAA receptor research.
Synapse
21:189-274[Web of Science][Medline].
-
Ron D,
Chen C-H,
Caldwell J,
Jamieson L,
Orr E,
Mochly-Rosen D
(1994)
Cloning of an intracellular receptor for protein kinase C: a homolog of the
subunits of the G-proteins.
Proc Natl Acad Sci USA
91:839-843[Abstract/Free Full Text]. -
Ron D,
Jiang Z,
Yao L,
Vagts A,
Diamond I,
Gordon A
(1999)
Coordinated movement of RACK-1 with activated
II PKC.
J Biol Chem
274:27039-27046[Abstract/Free Full Text]. -
Smith DB,
Johnson KS
(1988)
Single step purification of polypeptides expressed in E. coli as fusions with glutathione S-transferase.
Gene
67:31-40[Web of Science][Medline].
-
Swope SL,
Huganir RL
(1993)
Molecular cloning of two abundant protein tyrosine kinases in Torpedo electric organ that associate with the acetylcholine receptor.
J Biol Chem
268:25152-25161[Abstract/Free Full Text].
-
Tretter V,
Ehya N,
Fuchs K,
Sieghart W
(1997)
Stoichiometry and assembly of a recombinant GABAA receptor subtype.
J Neurosci
17:2728-2737[Abstract/Free Full Text].
-
Westphal RS,
Tavalin SJ,
Lin JW,
Alto NM,
Fraser IDC,
Langeberg LK,
Sheng M,
Scott JD
(1999)
Regulation of NMDA receptors by an associated phosphatase-kinase signaling complex.
Science
285:93-96[Abstract/Free Full Text].
-
Yarwood SJ,
Steele MR,
Scotland G,
Houslay MD,
Bolger GB
(1999)
The RACK-1 signaling scaffold protein selectively interacts with the cAMP-specific phosphodiesterase PDE4D5 isoform.
J Biol Chem
274:14909-14917[Abstract/Free Full Text].
-
Ymer S,
Schofield PR,
Draguhn A,
Werner P,
Kohler M,
Seeburg PH
(1989)
GABAA receptor
subunit heterogeneity: functional expression of cloned cDNAs.
EMBO J
8:1665-1670[Web of Science][Medline]. -
Yu X-M,
Askalan R,
Keil GJ,
Salter MW
(1997)
NMDA channel regulation by channel-associated protein tyrosine kinase Src.
Science
275:674-676[Abstract/Free Full Text].
Copyright © 2002 Society for Neuroscience 0270-6474/02/22156353-09$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
M. Fujii, T. Kanematsu, H. Ishibashi, K. Fukami, T. Takenawa, K. I. Nakayama, S. J. Moss, J. Nabekura, and M. Hirata
Phospholipase C-related but Catalytically Inactive Protein Is Required for Insulin-induced Cell Surface Expression of {gamma}-Aminobutyric Acid Type A Receptors
J. Biol. Chem.,
February 12, 2010;
285(7):
4837 - 4846.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. C. Jacob, Q. Wan, M. Vithlani, R. S. Saliba, F. Succol, M. N. Pangalos, and S. J. Moss
GABAA receptor membrane trafficking regulates spine maturity
PNAS,
July 28, 2009;
106(30):
12500 - 12505.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Terunuma, J. Xu, M. Vithlani, W. Sieghart, J. Kittler, M. Pangalos, P. G. Haydon, D. A. Coulter, and S. J. Moss
Deficits in Phosphorylation of GABAA Receptors by Intimately Associated Protein Kinase C Activity Underlie Compromised Synaptic Inhibition during Status Epilepticus
J. Neurosci.,
January 9, 2008;
28(2):
376 - 384.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Wanaverbecq, A. Semyanov, I. Pavlov, M. C. Walker, and D. M. Kullmann
Cholinergic Axons Modulate GABAergic Signaling among Hippocampal Interneurons via Postsynaptic {alpha}7 Nicotinic Receptors
J. Neurosci.,
May 23, 2007;
27(21):
5683 - 5693.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. S. Sossin
Isoform specificity of protein kinase Cs in synaptic plasticity
Learn. Mem.,
April 2, 2007;
14(4):
236 - 246.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Mizokami, T. Kanematsu, H. Ishibashi, T. Yamaguchi, I. Tanida, K. Takenaka, K. I. Nakayama, K. Fukami, T. Takenawa, E. Kominami, et al.
Phosholipase C-Related Inactive Protein Is Involved in Trafficking of {gamma}2 Subunit-Containing GABAA Receptors to the Cell Surface
J. Neurosci.,
February 14, 2007;
27(7):
1692 - 1701.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Palma, G. Torchia, C. Limatola, F. Trettel, A. Arcella, G. Cantore, G. Di Gennaro, M. Manfredi, V. Esposito, P. P. Quarato, et al.
BDNF modulates GABAA receptors microtransplanted from the human epileptic brain to Xenopus oocytes
PNAS,
February 1, 2005;
102(5):
1667 - 1672.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Yang, G. Liu, S. I. Zakharov, J. P. Morrow, V. O. Rybin, S. F. Steinberg, and S. O. Marx
Ser1928 Is a Common Site for Cav1.2 Phosphorylation by Protein Kinase C Isoforms
J. Biol. Chem.,
January 7, 2005;
280(1):
207 - 214.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Acuna-Goycolea and A. van den Pol
Glucagon-Like Peptide 1 Excites Hypocretin/Orexin Neurons by Direct and Indirect Mechanisms: Implications for Viscera-Mediated Arousal
J. Neurosci.,
September 15, 2004;
24(37):
8141 - 8152.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. I. Charych, W. Yu, R. Li, D. R. Serwanski, C. P. Miralles, X. Li, B. Y. Yang, N. Pinal, R. Walikonis, and A. L. De Blas
A Four PDZ Domain-containing Splice Variant Form of GRIP1 Is Localized in GABAergic and Glutamatergic Synapses in the Brain
J. Biol. Chem.,
September 10, 2004;
279(37):
38978 - 38990.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Meier and R. Grantyn
Preferential accumulation of GABAA receptor {gamma}2L, not {gamma}2S, cytoplasmic loops at rat spinal cord inhibitory synapses
J. Physiol.,
September 1, 2004;
559(2):
355 - 365.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Terunuma, I.-S. Jang, S. H. Ha, J. T. Kittler, T. Kanematsu, J. N. Jovanovic, K. I. Nakayama, N. Akaike, S. H. Ryu, S. J. Moss, et al.
GABAA Receptor Phospho-Dependent Modulation Is Regulated by Phospholipase C-Related Inactive Protein Type 1, a Novel Protein Phosphatase 1 Anchoring Protein
J. Neurosci.,
August 11, 2004;
24(32):
7074 - 7084.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. N. Jovanovic, P. Thomas, J. T. Kittler, T. G. Smart, and S. J. Moss
Brain-Derived Neurotrophic Factor Modulates Fast Synaptic Inhibition by Regulating GABAA Receptor Phosphorylation, Activity, and Cell-Surface Stability
J. Neurosci.,
January 14, 2004;
24(2):
522 - 530.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. Wardle and M.-m. Poo
Brain-Derived Neurotrophic Factor Modulation of GABAergic Synapses by Postsynaptic Regulation of Chloride Transport
J. Neurosci.,
September 24, 2003;
23(25):
8722 - 8732.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|